Sun D-Q, Jin Y, Wang T-Y, Zheng KI, Rios RS, Zhang H-Y, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433.
Article CAS PubMed Google Scholar
D’Agati VD, Chagnac A, de Vries APJ, Levi M, Porrini E, Herman-Edelstein M, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–71.
Article CAS PubMed Google Scholar
Gregg EW, Shaw JE. Global health effects of overweight and obesity. N Engl J Med. 2017;377(1):80–1.
Wei L, Li Y, Yu Y, Xu M, Chen H, Li L, et al. Obesity-related Glomerulopathy: from mechanism to therapeutic target. Diabetes Metab Syndr Obes. 2021;14:4371–80.
Article CAS PubMed PubMed Central Google Scholar
Wang Z, Huang W, Li H, Tang L, Sun H, Liu Q, et al. Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats. Ren Fail. 2018;40(1):175–82.
Article CAS PubMed PubMed Central Google Scholar
Yang P, Xiao Y, Luo X, Zhao Y, Zhao L, Wang Y, et al. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice. J Lipid Res. 2017;58(7):1417–27.
Article CAS PubMed PubMed Central Google Scholar
Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5(12):713–21.
Article CAS PubMed Google Scholar
de Vries APJ, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417–26.
Weber GJ, Foster J, Pushpakumar SB, Sen U. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation. Pharmacol Res. 2018;134:157–65.
Article CAS PubMed PubMed Central Google Scholar
Zaky A, Glastras SJ, Wong MYW, Pollock CA, Saad S. The role of the gut microbiome in diabetes and obesity-related kidney disease. Int J Mol Sci. 2021;22(17):9641. https://doi.org/10.3390/ijms22179641.
Article CAS PubMed PubMed Central Google Scholar
Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312–9.
Article CAS PubMed Google Scholar
Navalón-Monllor V, Soriano-Romaní L, Silva M, Hazas Las, de MCL, Hernando-Quintana N, Suárez Diéguez T, et al. Microbiota dysbiosis caused by dietetic patterns as a promoter of Alzheimer’s disease through metabolic syndrome mechanisms. Food Funct. 2023;14(16):7317–34.
Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230–7.
Article CAS PubMed Google Scholar
Ji C, Lu F, Wu Y, Lu Z, Mo Y, Han L, et al. Rhubarb Enema Increasing Short-Chain Fatty acids that improves the intestinal Barrier disruption in CKD may be related to the regulation of Gut Dysbiosis. Biomed Res Int. 2022;2022:1896781.
Article PubMed PubMed Central Google Scholar
Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y, et al. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma. Cell Death Dis. 2019;10(10):757.
Article PubMed PubMed Central Google Scholar
Guo H, Song Y, Li F, Fan Y, Li Y, Zhang C, et al. ACT001 suppressing M1 polarization against inflammation via NF-κB and STAT1 signaling pathways alleviates acute lung injury in mice. Int Immunopharmacol. 2022;110:108944.
Article CAS PubMed Google Scholar
Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10(13):5943–56. https://doi.org/10.7150/thno.41498.
Article CAS PubMed PubMed Central Google Scholar
Cai L, Gong Q, Qi L, Xu T, Suo Q, Li X, et al. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway. Cell Commun Signal. 2022;20(1):56.
Article CAS PubMed PubMed Central Google Scholar
Luo H, Liu X, Liu H, Wang Y, Xu K, Li J, et al. ACT001 Ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway. Biomed Pharmacother. 2023;163:114808.
Article CAS PubMed Google Scholar
Zhou H, Niu B, Wu X, Chu W, Zhou Y, Chen Z, et al. iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice. Sci Rep. 2023;13(1):11336.
Article CAS PubMed PubMed Central Google Scholar
Li X, Xiao Y, Huang Y, Song L, Li M, Ren Z. Lactobacillus gasseri RW2014 ameliorates hyperlipidemia by modulating bile acid metabolism and gut microbiota composition in rats. Nutrients. 2022;14(23):4945. https://doi.org/10.3390/nu14234945.
Article CAS PubMed PubMed Central Google Scholar
Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, et al. The AMPK pathway in fatty liver disease. Front Physiol. 2022;13:970292.
Article PubMed PubMed Central Google Scholar
Chen L, Li L, Han Y, Lv B, Zou S, Yu Q. Tong-fu-li-fei decoction exerts a protective effect on intestinal barrier of sepsis in rats through upregulating ZO-1/occludin/claudin-1 expression. J Pharmacol Sci. 2020;143(2):89–96.
Article CAS PubMed Google Scholar
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091–103.
Article CAS PubMed Google Scholar
Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, et al. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A. J Am Soc Nephrol. 2020;31(6):1267–81.
Article CAS PubMed PubMed Central Google Scholar
Cao H, Liu J, Shen P, Cai J, Han Y, Zhu K, et al. Protective effect of Naringin on DSS-Induced Ulcerative Colitis in mice. J Agric Food Chem. 2018;66(50):13133–40.
Article CAS PubMed Google Scholar
Li Z, Song Y, Xu W, Chen J, Zhou R, Yang M, et al. Pulsatilla chinensis saponins improve SCFAs regulating GPR43-NLRP3 signaling pathway in the treatment of ulcerative colitis. J Ethnopharmacol. 2023;308:116215.
Article CAS PubMed Google Scholar
Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829.
Al Mahri S, Malik SS, Al Ibrahim M, Haji E, Dairi G, Mohammad S. Free Fatty Acid Receptors (FFARs) in adipose: physiological role and therapeutic outlook. Cells. 2022;11(4):750. https://doi.org/10.3390/cells11040750.
Article CAS PubMed PubMed Central Google Scholar
Zeng X, Li J, Shan W, Lai Z, Zuo Z. Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood. Microbiome. 2023;11(1):204.
Article CAS PubMed PubMed Central Google Scholar
Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway. Arch Biochem Biophys. 2019;672:108057.
Article CAS PubMed Google Scholar
Deng M, Qu F, Chen L, Liu C, Zhang M, Ren F, et al. SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD. J Endocrinol. 2020;245(3):425–37.
Article CAS PubMed Google Scholar
Juszczak F, Caron N, Mathew AV, Declèves AE. Critical role for AMPK in metabolic disease-induced chronic kidney disease. Int J Mol Sci. 2020;21(21):7994. https://doi.org/10.3390/ijms21217994.
Article CAS PubMed PubMed Central Google Scholar
Declèves A-E, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, et al. Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. Kidney Int. 2014;85(3):611–23.
Comments (0)